CD274 and neoplasm: The HR difference of survival among the three subgroups including patients that had a PD‐L1 tumor proportion score (TPS) <1%, 1–49%, and TPS ≥50%, was statistically significant (OS: difference p < 0.01; PFS; difference p = .01).